Quant Healthcare Fund Datagrid
Category Pharma Fund
BMSMONEY Rank N/A
Rating N/A
Growth Option 11-06-2026
NAV ₹16.13(R) +0.01% ₹16.92(D) +0.02%
Returns 1Y 3Y 5Y 7Y 10Y
Lumpsum Regular 2.86% -% -% -% -%
Direct 4.52% -% -% -% -%
Nifty Pharma TRI 11.11% 24.59% 11.78% 17.62% 9.3%
SIP (XIRR) Regular 10.49% -% -% -% -%
Direct 12.25% -% -% -% -%
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
Fund AUM As on: 30/12/2025 379 Cr
Top Pharma Fund
Fund Name Rank Rating
Mirae Asset Healthcare Fund -
Aditya Birla Sun Life Pharma & Healthcare Fund -
Uti Healthcare Fund -
Sbi Healthcare Opportunities Fund -
Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund -
Nippon India Pharma Fund -
Tata India Pharma & Healthcare Fund -

NAV Date: 11-06-2026

Scheme Name NAV Rupee Change Percent Change
quant Healthcare Fund - Growth Option - Regular Plan 16.13
0.0000
0.0100%
quant Healthcare Fund - IDCW Option - Regular Plan 16.13
0.0000
0.0100%
quant Healthcare Fund - Growth Option - Direct Plan 16.92
0.0000
0.0200%
quant Healthcare Fund - IDCW Option - Direct Plan 16.92
0.0000
0.0200%

Review Date: 11-06-2026

Investors beware: Mutual Fund investments are subject to market risks. Please read the scheme related documents carefully.

Data Source: www.amfiindia.com

SEBI Categorization


KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % -1.21 0.67
0.63
-1.21 | 4.43 16 | 16 Poor
3M Return % 9.68 4.22
8.20
4.19 | 12.24 6 | 16 Good
6M Return % 7.42 7.04
7.82
2.66 | 13.15 9 | 16 Average
1Y Return % 2.86 11.11
8.95
2.86 | 17.27 15 | 15 Poor
1Y SIP Return % 10.49
14.36
5.74 | 23.65 12 | 15 Average
Return data last Updated On : June 11, 2026.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : March 30, 2026
KPIs: Key Performance Indicators

Rotate the phone! Best viewed in landscape mode on mobile.
KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % -1.07 0.67 0.75 -1.07 | 4.55 16 | 16 Poor
3M Return % 10.13 4.22 8.57 4.42 | 12.61 5 | 16 Good
6M Return % 8.29 7.04 8.56 3.38 | 14.06 9 | 16 Average
1Y Return % 4.52 11.11 10.42 4.52 | 18.63 15 | 15 Poor
1Y SIP Return % 12.25 15.87 7.25 | 25.04 11 | 15 Average
Return data last Updated On : June 11, 2026.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : March 30, 2026
KPIs: Key Performance Indicators

Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.


Date Quant Healthcare Fund NAV Regular Growth Quant Healthcare Fund NAV Direct Growth
11-06-2026 16.1348 16.9178
10-06-2026 16.1326 16.9147
09-06-2026 16.3293 17.1202
08-06-2026 16.1458 16.927
05-06-2026 16.2556 17.0398
04-06-2026 16.1437 16.9218
03-06-2026 16.2064 16.9868
02-06-2026 16.1453 16.9219
01-06-2026 16.0776 16.8502
29-05-2026 16.2694 17.0489
27-05-2026 16.3162 17.0965
26-05-2026 16.3156 17.0951
25-05-2026 16.2999 17.0778
22-05-2026 16.1724 16.942
21-05-2026 16.3496 17.1269
20-05-2026 16.3574 17.1343
19-05-2026 16.1714 16.9387
18-05-2026 16.0667 16.8283
15-05-2026 16.1732 16.9376
14-05-2026 16.2649 17.0328
13-05-2026 16.1752 16.9381
12-05-2026 16.0337 16.7892
11-05-2026 16.3324 17.1012

Fund Launch Date: 17/Jul/2023
Fund Category: Pharma Fund
Investment Objective: The primary investment objective of the scheme is to provide capital appreciation by investing in equity and equity related instruments including derivatives and debt and money market instruments. However, there can be no assurance that the investment objective of the Scheme will be realized, as actual market movements may be at variance with anticipated trends.
Fund Description: The primary investment objective of the scheme is to provide capital appreciation by investing in equity and equity related instruments including derivatives and debt and money market instruments. However, there can be no assurance that the investment objective of the Scheme will be realized, as actual market movements may be at variance with anticipated trends.
Fund Benchmark: BSE Healthcare TRI
Source: Fund FactSheet

Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.